UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Convertible And Redeemable Series A-2 Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020	$ 137,145			$ 259,427	$ (122,353)	$ 71
Beginning balance, shares at Dec. 31, 2020			24,932,527
Beginning balance at Dec. 31, 2020		$ 152,928
Beginning balance, shares at Dec. 31, 2020		17,500
Net loss	(12,931)				(12,931)
Stock-based compensation	1,805			1,805
Dividend payment to the Series A-2 preferred shareholders	(4,100)			(4,100)
Common stock issued	4,456			4,456
Common stock issued, shares			506,330
Accumulated other comprehensive income (loss)	29					29
Ending balance at Mar. 31, 2021	126,404			261,588	(135,284)	100
Ending balance, shares at Mar. 31, 2021		17,500
Ending balance at Mar. 31, 2021		$ 152,928
Ending balance, shares at Mar. 31, 2021			25,438,857
Beginning balance at Dec. 31, 2020	137,145			259,427	(122,353)	71
Beginning balance, shares at Dec. 31, 2020			24,932,527
Beginning balance at Dec. 31, 2020		$ 152,928
Beginning balance, shares at Dec. 31, 2020		17,500
Net loss	$ (23,853)
Dividend payment to the Series A-2 preferred shareholders		$ (12,300)
Common stock issued, shares	1,593,317
Ending balance at Sep. 30, 2021	$ 145,698			291,850	(146,206)	54
Ending balance, shares at Sep. 30, 2021		17,500
Ending balance at Sep. 30, 2021		$ 152,928
Ending balance, shares at Sep. 30, 2021			26,525,844
Beginning balance at Mar. 31, 2021	126,404			261,588	(135,284)	100
Beginning balance, shares at Mar. 31, 2021			25,438,857
Beginning balance at Mar. 31, 2021		$ 152,928
Beginning balance, shares at Mar. 31, 2021		17,500
Net loss	(13,148)				(13,148)
Stock-based compensation	2,417			2,417
Dividend payment to the Series A-2 preferred shareholders	(4,100)			(4,100)
Common stock issued	27,460			27,460
Common stock issued, shares			669,331
Accumulated other comprehensive income (loss)	28					28
Ending balance at Jun. 30, 2021	139,061			287,365	(148,432)	128
Ending balance, shares at Jun. 30, 2021		17,500
Ending balance at Jun. 30, 2021		$ 152,928
Ending balance, shares at Jun. 30, 2021			26,108,188
Net loss	2,226				2,226
Stock-based compensation	2,365			2,365
Dividend payment to the Series A-2 preferred shareholders	(4,100)	$ (4,100)		(4,100)
Common stock issued	$ 6,220			6,220
Common stock issued, shares	417,656		417,656
Accumulated other comprehensive income (loss)	$ (74)					(74)
Ending balance at Sep. 30, 2021	145,698			291,850	(146,206)	54
Ending balance, shares at Sep. 30, 2021		17,500
Ending balance at Sep. 30, 2021		$ 152,928
Ending balance, shares at Sep. 30, 2021			26,525,844
Beginning balance at Dec. 31, 2021	316,501			464,143	(147,678)	36
Beginning balance, shares at Dec. 31, 2021			29,619,921
Beginning balance at Dec. 31, 2021		$ 152,928
Beginning balance, shares at Dec. 31, 2021		17,500
Net loss	(7,536)				(7,536)
Stock-based compensation	10,425			10,425
Dividend payment to the Series A-2 preferred shareholders	(4,100)			(4,100)
Common stock issued	429			429
Common stock issued, shares			55,896
Accumulated other comprehensive income (loss)	45					45
Ending balance at Mar. 31, 2022	315,764			470,897	(155,214)	81
Ending balance, shares at Mar. 31, 2022		17,500
Ending balance at Mar. 31, 2022		$ 152,928
Ending balance, shares at Mar. 31, 2022			29,675,817
Beginning balance at Dec. 31, 2021	316,501			464,143	(147,678)	36
Beginning balance, shares at Dec. 31, 2021			29,619,921
Beginning balance at Dec. 31, 2021		$ 152,928
Beginning balance, shares at Dec. 31, 2021		17,500
Net loss	$ (21,007)
Dividend payment to the Series A-2 preferred shareholders		$ (12,300)
Common stock issued, shares	87,582
Ending balance at Sep. 30, 2022	$ 316,398			485,030	(168,685)	53
Ending balance, shares at Sep. 30, 2022		17,500
Ending balance at Sep. 30, 2022		$ 152,928
Ending balance, shares at Sep. 30, 2022			29,707,503
Beginning balance at Mar. 31, 2022	315,764			470,897	(155,214)	81
Beginning balance, shares at Mar. 31, 2022			29,675,817
Beginning balance at Mar. 31, 2022		$ 152,928
Beginning balance, shares at Mar. 31, 2022		17,500
Net loss	(7,751)				(7,751)
Stock-based compensation	10,932			10,932
Dividend payment to the Series A-2 preferred shareholders	(4,100)			(4,100)
Common stock issued	54			54
Common stock issued, shares			3,575
Accumulated other comprehensive income (loss)	(48)					(48)
Ending balance at Jun. 30, 2022	314,851			477,783	(162,965)	33
Ending balance, shares at Jun. 30, 2022		17,500
Ending balance at Jun. 30, 2022		$ 152,928
Ending balance, shares at Jun. 30, 2022			29,679,392
Net loss	(5,720)				(5,720)
Stock-based compensation	11,018			11,018
Dividend payment to the Series A-2 preferred shareholders	(4,100)	$ (4,100)		(4,100)
Common stock issued	$ 329			329
Common stock issued, shares	28,111		28,111
Accumulated other comprehensive income (loss)	$ 20					20
Ending balance at Sep. 30, 2022	$ 316,398			$ 485,030	$ (168,685)	$ 53
Ending balance, shares at Sep. 30, 2022		17,500
Ending balance at Sep. 30, 2022		$ 152,928
Ending balance, shares at Sep. 30, 2022			29,707,503